Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             29 results found
no title author magazine year volume issue page(s) type
1 A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy Guarneri, V.

20 7 p. 1193-1198
article
2 A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer Colleoni, M.

20 7 p. 1178-1184
article
3 BRCA2 splice site mutations in an Italian breast/ovarian cancer family Díez, O.

20 7 p. 1285
article
4 Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention Han, J.W.

20 7 p. 1170-1177
article
5 Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer Sternberg, C.N.

20 7 p. 1264-1269
article
6 Editorial Board
20 7 p. ii-iii
article
7 Effectiveness of organised versus opportunistic mammography screening Bulliard, J.-L.

20 7 p. 1199-1202
article
8 Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy Hadji, P.

20 7 p. 1203-1209
article
9 FDG–PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value Markova, J.

20 7 p. 1270-1274
article
10 Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer Tan, E.H.

20 7 p. 1249-1256
article
11 Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP? Khasraw, M.

20 7 p. 1282-1283
article
12 in this issue
20 7 p. 1151
article
13 MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events de Vogel, S.

20 7 p. 1216-1222
article
14 Palliative sedation therapy does not hasten death: results from a prospective multicenter study Maltoni, M.

20 7 p. 1163-1169
article
15 Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) Katsumata, N.

20 7 p. 1210-1215
article
16 Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma Nutting, C.M.

20 7 p. 1275-1279
article
17 Phase II trial of docetaxel–irinotecan combination in advanced esophageal cancer Burtness, B.

20 7 p. 1242-1248
article
18 Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer Kemeny, N.

20 7 p. 1236-1241
article
19 PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma Buhmeida, A.

20 7 p. 1230-1235
article
20 Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer Frasci, G.

20 7 p. 1185-1192
article
21 Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer Cohen, S.J.

20 7 p. 1223-1229
article
22 Reply to BRCA2 splice site mutations in an Italian breast/ovarian cancer family Pensabene, M.

20 7 p. 1285-1286
article
23 Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis Glezerman, I.G.

20 7 p. 1283-1285
article
24 Table of Contents
20 7 p. iv-v
article
25 Tamoxifen contraindicated in women with hereditary angioedema? Rousset-Jablonski, C.

20 7 p. 1281-1282
article
26 The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma Planchard, D.

20 7 p. 1257-1263
article
27 The use of sedation to relieve cancer patients' suffering at the end of life: addressing critical issues Cherny, N.

20 7 p. 1153-1155
article
28 Travel warning with capecitabine Wong, M.

20 7 p. 1281
article
29 What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? Barrios, C.H.

20 7 p. 1157-1162
article
                             29 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands